Gary Steven Gilkeson

Gary Steven Gilkeson's AcademicInfluence.com Rankings

Philosophy

#8958

World Rank

#12445

Historical Rank

Logic

#5963

World Rank

#7429

Historical Rank

philosophy Degrees

Gary Steven Gilkeson

Biology

#12237

World Rank

#15701

Historical Rank

Immunology

#813

World Rank

#836

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Gary Steven Gilkeson's Degrees

Doctorate Medicine University of North Carolina at Chapel Hill
PhD Immunology University of North Carolina at Chapel Hill

Why Is Gary Steven Gilkeson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gary Steven Gilkeson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. (1996) (788)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. (2005) (673)
Vitamin D deficiency in systemic lupus erythematosus. (2006) (461)
The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L- arginine (1994) (441)
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. (2010) (436)
Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study (2010) (395)
Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. (2003) (377)
Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. (1991) (374)
Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci (1992) (356)
Human polymorphism at microRNAs and microRNA target sites. (2013) (330)
A nonsynonymous functional variant in integrin-αM (encoded by ITGAM) is associated with systemic lupus erythematosus (2008) (311)
Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice 1 (2003) (296)
Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus (2011) (267)
Transancestral mapping and genetic load in systemic lupus erythematosus (2017) (253)
Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. (2008) (252)
A Meta-Analysis Identifies New Loci Associated with Body Mass index in Individuals of African Ancestry (2013) (244)
Estrogen Receptors in Immunity and Autoimmunity (2011) (241)
Identification of IRAK1 as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus (2009) (236)
Allogeneic Mesenchymal Stem Cell Transplantation in Severe and Refractory Systemic Lupus Erythematosus: 4 Years of Experience (2013) (234)
Evaluation of the TREX1 gene in a large multi-ancestral lupus cohort (2011) (231)
Hormonal, environmental, and infectious risk factors for developing systemic lupus erythematosus. (1998) (221)
Nephritogenic autoantibodies in lupus: current concepts and continuing controversies. (1996) (221)
Modulation of Renal Disease in MRL/lpr Mice Genetically Deficient in the Alternative Complement Pathway Factor B1 (2000) (207)
Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States (2002) (203)
Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. (1989) (202)
Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. (2002) (196)
Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. (2002) (194)
Association of Genetic Variants in Complement Factor H and Factor H-Related Genes with Systemic Lupus Erythematosus Susceptibility (2011) (193)
Mechanisms of tissue injury in lupus nephritis (2011) (184)
A role for sphingosine kinase 1 in dextran sulfate sodium‐induced colitis (2009) (184)
Induction of cross-reactive anti-dsDNA antibodies in preautoimmune NZB/NZW mice by immunization with bacterial DNA. (1995) (183)
Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients (1996) (175)
A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice. (2005) (174)
Retroperitoneal fibrosis. A true connective tissue disease. (1996) (172)
The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus (2010) (166)
A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. (2009) (162)
Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. (2012) (159)
ETS transcription factors and regulation of immunity (2006) (158)
Occupational risk factors for the development of systemic lupus erythematosus. (2004) (158)
Role for Msh5 in the regulation of Ig class switch recombination (2007) (151)
Bone marrow transplantation reproduces the tristetraprolin-deficiency syndrome in recombination activating gene-2 (-/-) mice. Evidence that monocyte/macrophage progenitors may be responsible for TNFalpha overproduction. (1997) (150)
Modulation of Renal Disease in MRL/lpr Mice by Suberoylanilide Hydroxamic Acid1 (2004) (150)
Complement Component C3 Is Not Required for Full Expression of Immune Complex Glomerulonephritis in MRL/lpr Mice (2001) (149)
Early disease onset is predicted by a higher genetic risk for lupus and is associated with a more severe phenotype in lupus patients (2010) (149)
Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus (2008) (142)
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus (2011) (135)
A polymorphism within IL21R confers risk for systemic lupus erythematosus. (2009) (121)
Identification of novel genetic susceptibility loci in African American lupus patients in a candidate gene association study. (2011) (119)
Clinical and Serologic Manifestations of Autoimmune Disease in MRL-lpr/lpr Mice Lacking Nitric Oxide Synthase Type 2 (1997) (117)
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus (2011) (117)
Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. (2002) (117)
Effects of complement factor D deficiency on the renal disease of MRL/lpr mice. (2004) (116)
A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases (2017) (112)
Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA (1996) (111)
Early detection of carpal erosions in patients with rheumatoid arthritis: a pilot study of magnetic resonance imaging. (1988) (110)
Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production (2013) (105)
Association of Epstein-Barr virus with systemic lupus erythematosus: effect modification by race, age, and cytotoxic T lymphocyte-associated antigen 4 genotype. (2005) (104)
MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus (2013) (99)
X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome (2015) (96)
Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic lupus erythematosus in multiple ancestral groups (2012) (95)
The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. (2008) (95)
The histone deacetylase inhibitor trichostatin A upregulates regulatory T cells and modulates autoimmunity in NZB/W F1 mice. (2008) (95)
A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus. (1990) (92)
Impact of estrogen receptor deficiency on disease expression in the NZM2410 lupus prone mouse. (2008) (92)
Eliminating complement factor D reduces photoreceptor susceptibility to light-induced damage. (2007) (90)
Analysis of autosomal genes reveals gene–sex interactions and higher total genetic risk in men with systemic lupus erythematosus (2011) (89)
High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. (2009) (88)
Identification of a systemic lupus erythematosus susceptibility locus at 11p13 between PDHX and CD44 in a multiethnic study. (2011) (88)
Mouse models of lupus: what they tell us and what they don’t (2018) (86)
Meta-analysis and Imputation Identifies a 109 kb Risk Haplotype Spanning TNFAIP3 Associated with Lupus Nephritis and Hematologic Manifestations (2009) (85)
ITGAM coding variant (rs1143679) influences the risk of renal disease, discoid rash and immunological manifestations in patients with systemic lupus erythematosus with European ancestry (2009) (84)
Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States (2003) (84)
Genetic Sphingosine Kinase 1 Deficiency Significantly Decreases Synovial Inflammation and Joint Erosions in Murine TNF-α–Induced Arthritis (2010) (82)
Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian-European populations. (2012) (81)
Genetic associations of LYN with systemic lupus erythematosus (2009) (81)
Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to lupus and differential gene expression in patients with systemic lupus erythematosus. (2009) (80)
Allogeneic mesenchymal stem cell transplantation for lupus nephritis patients refractory to conventional therapy (2014) (79)
Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells. (2006) (79)
A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels. (1996) (79)
Osteopontin and Systemic Lupus Erythematosus Association: A Probable Gene-Gender Interaction (2008) (78)
Prospective measure of serum 3-nitrotyrosine levels in systemic lupus erythematosus: correlation with disease activity. (1999) (78)
Inhibition of Mesangial Cell Nitric Oxide in MRL/lpr Mice by Prostaglandin J2 and Proliferator Activation Receptor-γ Agonists1 (2000) (77)
The lupus family registry and repository. (2011) (75)
Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK (2011) (74)
The biology of nitric oxide and other reactive intermediates in systemic lupus erythematosus. (2006) (73)
Sociodemographic associations with early disease damage in patients with systemic lupus erythematosus. (2007) (73)
Genomic view of systemic autoimmunity in MRLlpr mice (2006) (73)
Two aspects of the clinical and humanistic burden of systemic lupus erythematosus: mortality risk and quality of life early in the course of disease. (2008) (72)
Smoking and use of hair treatments in relation to risk of developing systemic lupus erythematosus. (2001) (72)
Association of two independent functional risk haplotypes in TNIP1 with systemic lupus erythematosus. (2012) (72)
The Transcription Factor Fli-1 Modulates Marginal Zone and Follicular B Cell Development in Mice1 (2008) (71)
ABIN1 dysfunction as a genetic basis for lupus nephritis. (2013) (70)
Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis (2008) (70)
A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus (2018) (69)
The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice. (2011) (69)
Comparison of autoantibody specificities between traditional and bead-based assays in a large, diverse collection of patients with systemic lupus erythematosus and family members. (2012) (68)
Low-Dose Targeted Complement Inhibition Protects against Renal Disease and Other Manifestations of Autoimmune Disease in MRL/lpr Mice1 (2008) (68)
The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share. (2014) (67)
The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. (1993) (66)
Autoantibody prevalence and lupus characteristics in a unique African American population. (2008) (65)
Induction of immune-mediated glomerulonephritis in normal mice immunized with bacterial DNA. (1993) (63)
Allogenic Mesenchymal Stem Cell Transplantation Ameliorates Nephritis in Lupus Mice via Inhibition of B-Cell Activation (2013) (63)
Evidence for gene-gene epistatic interactions among susceptibility loci for systemic lupus erythematosus. (2012) (63)
Genetic polymorphisms in tumor necrosis factor (TNF)-α and TNF-β in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1α-889 C/T polymorphism (2004) (62)
Decreased Expression of the Ets Family Transcription Factor Fli-1 Markedly Prolongs Survival and Significantly Reduces Renal Disease in MRL/lpr Mice1 (2004) (61)
Enrichment of Anti-Glomerular Antigen Antibody-Producing Cells in the Kidneys of MRL/MpJ-Faslpr Mice1 (2004) (61)
Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. (2014) (60)
Prostaglandin J(2) inhibition of mesangial cell iNOS expression. (2001) (60)
Effect of late modulation of nitric oxide production on murine lupus. (1997) (59)
Trans-Ancestral Studies Fine Map the SLE-Susceptibility Locus TNFSF4 (2013) (58)
PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes (2013) (58)
Mediators of injury in lupus nephritis (2002) (57)
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis (2011) (57)
Variation in the ICAM1–ICAM4–ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries (2012) (57)
Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. (2002) (57)
Molecular characterization of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. Differences from spontaneous anti-DNA in the content and location of VH CDR3 arginines. (1993) (56)
The Role of Genetic Variation Near Interferon-Kappa in Systemic Lupus Erythematosus (2010) (56)
The Impact of Systemic Lupus Erythematosus on Employment (2009) (54)
Peroxynitrite Formation and Decreased Catalase Activity in Autoimmune MRL-lpr/lpr Mice (2000) (54)
Fine-mapping and transethnic genotyping establish IL2/IL21 genetic association with lupus and localize this genetic effect to IL21. (2011) (54)
A functional haplotype of UBE2L3 confers risk for systemic lupus erythematosus (2012) (54)
Glutathione S-transferase M null homozygosity and risk of systemic lupus erythematosus associated with sun exposure: a possible gene-environment interaction for autoimmunity. (2003) (54)
Differential effect of allogeneic versus syngeneic mesenchymal stem cell transplantation in MRL/lpr and (NZB/NZW)F1 mice. (2012) (53)
Differential Efficacy of Human Mesenchymal Stem Cells Based on Source of Origin (2014) (51)
CTLA-4 gene polymorphisms and systemic lupus erythematosus in a population-based study of whites and African-Americans in the southeastern United States (2004) (51)
Association of serum nitrate and nitrite levels with longitudinal assessments of disease activity and damage in systemic lupus erythematosus and lupus nephritis. (2008) (51)
Evaluation of TRAF6 in a large multiancestral lupus cohort. (2012) (51)
Anticardiolipin Antibodies and Osteonecrosis of the Femoral Head (1997) (51)
Identification of new SLE-associated genes with a two-step Bayesian study design (2009) (51)
The alternative pathway of complement is activated in the glomeruli and tubulointerstitium of mice with adriamycin nephropathy. (2007) (51)
Absence of functional alternative complement pathway alleviates lupus cerebritis (2007) (50)
Estrogen receptor alpha modulates Toll-like receptor signaling in murine lupus. (2012) (50)
Systemic lupus erythematosus. Diagnosis and treatment. (1997) (49)
Replication of the BANK1 genetic association with systemic lupus erythematosus in a European-derived population (2009) (49)
The dual role of complement in the progression of renal disease in NZB/W F(1) mice and alternative pathway inhibition. (2011) (48)
Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at risk individuals (2019) (47)
Increased expression of beta-arrestin 1 and 2 in murine models of rheumatoid arthritis: isoform specific regulation of inflammation. (2011) (47)
Peroxisome Proliferation-Activated Receptor (PPAR)γ Is Not Necessary for Synthetic PPARγ Agonist Inhibition of Inducible Nitric-Oxide Synthase and Nitric Oxide (2005) (46)
Nitric oxide synthase 2 promoter polymorphisms and systemic lupus erythematosus in african-americans. (2003) (46)
In vitro evaluation of the effects of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) on IL‐2 production in human T‐cells (2015) (46)
Discerning Risk of Disease Transition in Relatives of Systemic Lupus Erythematosus Patients Utilizing Soluble Mediators and Clinical Features (2017) (46)
A novel PPAR response element in the murine iNOS promoter. (2005) (45)
A role for estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) in collagen biosynthesis in mouse skin (2012) (45)
Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression (2013) (44)
Evaluation of C1q genomic region in minority racial groups of lupus (2009) (44)
Use of genetic knockouts to modulate disease expression in a murine model of lupus, MRL/Ipr mice (2002) (43)
Ethnic disparities among patients with systemic lupus erythematosus in South Carolina. (2008) (43)
Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy (2017) (43)
Interferon regulatory factor‐1 gene deletion decreases glomerulonephritis in MRL/lpr mice (2006) (42)
Developmental Immunotoxicity of Trichloroethylene (TCE): Studies in B6C3F1 Mice (2006) (41)
Genetic polymorphisms in tumor necrosis factor (TNF)-alpha and TNF-beta in a population-based study of systemic lupus erythematosus: associations and interaction with the interleukin-1alpha-889 C/T polymorphism. (2004) (41)
Association of PPP2CA polymorphisms with systemic lupus erythematosus susceptibility in multiple ethnic groups. (2011) (40)
A Link Between Plasma Microbial Translocation, Microbiome, and Autoantibody Development in First‐Degree Relatives of Systemic Lupus Erythematosus Patients (2019) (40)
Differential effects of 15‐deoxy‐Δ12,14‐prostaglandin J2 and a peroxisome proliferator‐activated receptor γ agonist on macrophage activation (2001) (39)
PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR‐GAMMA AGONISTS MODULATE MACROPHAGE ACTIVATION BY GRAM‐NEGATIVE AND GRAM‐POSITIVE BACTERIAL STIMULI (2003) (39)
Specificity of anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. (1991) (39)
Progesterone decreases gut permeability through upregulating occludin expression in primary human gut tissues and Caco-2 cells (2019) (38)
Lupus Risk Variant Increases pSTAT1 Binding and Decreases ETS1 Expression. (2015) (38)
Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways in Mesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus (2012) (38)
Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus (2016) (37)
Anti-cyclic citrullinated peptide antibody and rheumatoid factor isotypes in African Americans with early rheumatoid arthritis. (2006) (36)
Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans (2018) (35)
Molecular properties of anti-DNA induced in preautoimmune NZB/W mice by immunization with bacterial DNA. (1997) (35)
B lymphocytes confer immune tolerance via cell surface GARP-TGF-β complex. (2018) (35)
The antibody response of normal mice to immunization with single-stranded DNA of various species origin. (1989) (35)
A Critical Role of the Transcription Factor Fli‐1 in Murine Lupus Development by Regulation of Interleukin‐6 Expression (2014) (34)
Impact of Fli‐1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice (2010) (34)
Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE). (2014) (34)
Fli-1 transcription factor affects glomerulonephritis development by regulating expression of monocyte chemoattractant protein-1 in endothelial cells in the kidney. (2012) (32)
A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. (2010) (32)
Impact of sphingosine kinase 2 deficiency on the development of TNF-alpha-induced inflammatory arthritis (2013) (32)
Lupus risk variants in the PXK locus alter B-cell receptor internalization (2015) (31)
The influence of variable-region somatic mutations on the specificity and pathogenicity of murine monoclonal anti-DNA antibodies. (1995) (31)
Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms. (2007) (31)
Gut microbiota differently contributes to intestinal immune phenotype and systemic autoimmune progression in female and male lupus-prone mice (2019) (31)
A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis (2010) (31)
Peroxisome proliferator–activated receptor γ agonists: Potential use for treating chronic inflammatory diseases (2002) (30)
Thrombocytopenia in Mice Lacking the Carboxy-Terminal Regulatory Domain of the Ets Transcription Factor Fli1 (2010) (30)
Angiotensin-converting enzyme (insertion/deletion) and endothelial nitric oxide synthase polymorphisms in patients with systemic lupus erythematosus. (2004) (30)
Endothelial Nitric Oxide Synthase Reduces Crescentic and Necrotic Glomerular Lesions, Reactive Oxygen Production, and MCP1 Production in Murine Lupus Nephritis (2013) (29)
Estrogen decreases tight junction protein ZO-1 expression in human primary gut tissues. (2017) (29)
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (2009) (29)
Autoimmune Alterations Induced by the New Zealand Black Lbw2 Locus in BWF1 Mice1 (2005) (29)
A role for Fli-1 in B cell proliferation: implications for SLE pathogenesis. (2008) (29)
Multiple Autoantibodies Display Association with Lymphopenia, Proteinuria, and Cellular Casts in a Large, Ethnically Diverse SLE Patient Cohort (2012) (27)
Assessment of trichloroethylene (TCE) exposure in murine strains genetically-prone and non-prone to develop autoimmune disease (2009) (27)
Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus. (2007) (26)
Pregnancy outcomes among African–American patients with systemic lupus erythematosus compared with controls (2014) (26)
Genetic control of inflammatory arthritis in congenic lpr mice. (1989) (26)
Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (2009) (26)
Patterns of heavy and light chain utilization in the antibody response to single-stranded bacterial DNA in normal human subjects and patients with systemic lupus erythematosus. (1992) (26)
Immunological and Hematological Effects Observed in B6C3F1 Mice Exposed to JP-8 Jet Fuel for 14 Days (2004) (25)
Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice. (1998) (25)
Effect of anti-CD4 antibody treatment on inflammatory arthritis in MRL-lpr/lpr mice. (1992) (24)
The transcription factor Fli‐1 regulates monocyte, macrophage and dendritic cell development in mice (2013) (24)
Murine glomerulotropic monoclonal antibodies are highly oligoclonal and exhibit distinctive molecular features. (1996) (24)
Role of MHC-Linked Genes in Autoantigen Selection and Renal Disease in a Murine Model of Systemic Lupus Erythematosus1 (2006) (23)
Sex Differences in Monocyte Activation in Systemic Lupus Erythematosus (SLE) (2014) (23)
Hematopoetic and mesenchymal stem cell transplantation in the treatment of refractory systemic lupus erythematosus--where are we now? (2013) (23)
Pyridostigmine Bromide (PYR) Alters Immune Function in B6C3F1 Mice (2004) (23)
CT-04 Safety and efficacy of allogeneic umbilical cord-derived mesenchymal stem cells (MSCs) in patients with systemic lupus erythematosus: results of an open-label phase I study (2018) (22)
A plausibly causal functional lupus-associated risk variant in the STAT1–STAT4 locus (2018) (22)
Ets factors and a newly identified polymorphism regulate Fli1 promoter activity in lymphocytes. (2008) (21)
Inflammatory modulation of PPARγ expression and activity (2006) (21)
Genetic association of CD247 (CD3ζ) with SLE in a large-scale multiethnic study (2015) (20)
N,N,-diethyl-m-toluamide (DEET) suppresses humoral immunological function in B6C3F1 mice. (2009) (20)
Influence of VH CDR3 arginine and light chain pairing on DNA reactivity of a bacterial DNA-induced anti-DNA antibody from a BALB/c mouse. (1997) (19)
Detection of glomerular‐binding immune elements in murine lupus using a tissue‐based ELISA (1993) (19)
Early Ovariectomy Results in Reduced Numbers of CD11c+/CD11b+ Spleen Cells and Impacts Disease Expression in Murine Lupus (2016) (19)
Acetylation impacts Fli‐1‐driven regulation of granulocyte colony stimulating factor (2016) (18)
The fine specificity of monoclonal anti-DNA antibodies induced in normal mice by immunization with bacterial DNA. (1993) (18)
Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation. (2001) (18)
Genetic control of inflammatory arthritis and glomerulonephritis in congenic lpr mice and their F1 hybrids. (1991) (18)
Effect of genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production and renal disease in MRL/lpr mice. (2003) (17)
Cellular requirements for anti‐DNA production induced in mice by immunization with bacterial DNA (1990) (17)
Differences in Vϰ gene utilization and VH CDR3 sequence among anti‐DNA from C3H‐lpr mice and lupus mice with nephritis (1996) (17)
N-acetyl transferase genotypes in relation to risk of developing systemic lupus erythematosus. (2004) (17)
Estrogen Receptor Alpha Binding to ERE is Required for Full Tlr7- and Tlr9-Induced Inflammation. (2014) (17)
Peroxisome proliferation-activated receptor (PPAR)gamma is not necessary for synthetic PPARgamma agonist inhibition of inducible nitric-oxide synthase and nitric oxide. (2005) (16)
Effect of a genetic deficiency of terminal deoxynucleotidyl transferase on autoantibody production by C57BL6 Fas(lpr) mice. (2000) (16)
Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases. (2016) (16)
A highlight from the LUPUS 2014 meeting: eight great ideas (2015) (16)
Inducible Nitric Oxide Synthase Inhibitor SD-3651 Reduces Proteinuria in MRL/lpr Mice Deficient in the NOS2 Gene (2008) (15)
Adipose stem cells from chronic pancreatitis patients improve mouse and human islet survival and function (2017) (15)
Selective recognition of DNA antigenic determinants by murine monoclonal anti-DNA antibodies. (1990) (15)
Soluble CD16 in the treatment of murine lupus nephritis. (1998) (14)
Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production (2016) (14)
Estrogen Receptor Alpha Modulates Mesangial Cell Responses to Toll-Like Receptor Ligands (2014) (14)
Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA (2014) (14)
Lifetime exposure to trichloroethylene (TCE) does not accelerate autoimmune disease in MRL +/+ mice (2008) (14)
Are Microparticles the Missing Link between Thrombosis and Autoimmune Diseases? Involvement in Selected Rheumatologic Diseases (2014) (14)
Immunoglobulin GM and KM Allotypes in Systemic Lupus erythematosus (2001) (13)
Hemorrhage and Thrombus Formation in Early Experimental Osteonecrosis (2001) (13)
Association of reactive oxygen and nitrogen intermediate and complement levels with apoptosis of peripheral blood mononuclear cells in lupus patients. (2007) (13)
Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus (2014) (12)
Decreased expression of Fli‐1 in bone marrow‐derived haematopoietic cells significantly affects disease development in Murphy Roths Large/lymphoproliferation (MRL/lpr) mice (2009) (12)
Genetic associations of LYN with systemic lupus erythematosus (2010) (12)
Bone Marrow Transplantation Reproduces the Tristetraprolin-Deficiency Syndrome in Recombination Activating Gene-2 ( 2 / 2 ) Mice Evidence That Monocyte / Macrophage Progenitors May Be Responsible for TNF a Overproduction (2013) (12)
Peroxisome proliferator-activated receptor gamma agonists: potential use for treating chronic inflammatory diseases. (2002) (11)
Estrogen Receptor α Deficiency Modulates TLR Ligand–Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice (2015) (11)
Trans-Ethnic Mapping of BANK1 Identifies Two Independent SLE-Risk Linkage Groups Enriched for Co-Transcriptional Splicing Marks (2018) (11)
Inflammatory modulation of PPAR gamma expression and activity. (2006) (11)
Nitric Oxide Induces Apoptosis in Spleen Lymphocytes from MRL/Ipr Mice (2004) (11)
Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages (2021) (10)
Retroperitoneal fibrosis. The forgotten connective tissue disease. (1989) (10)
Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease. (2017) (10)
Targeting glycosphingolipid metabolism as a potential therapeutic approach for treating disease in female MRL/lpr lupus mice (2020) (10)
Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry (2013) (10)
Regulation of Fli1 gene expression and lupus. (2006) (10)
Genetic associations of leptin-related polymorphisms with systemic lupus erythematosus. (2015) (10)
Rigorous Plasma Microbiome Analysis Method Enables Disease Association Discovery in Clinic (2021) (9)
Expression of GM-CSF Is Regulated by Fli-1 Transcription Factor, a Potential Drug Target. (2020) (9)
Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli‐1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB × NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells (2021) (9)
The Induction of Anti-DNA Antibodies in Normal Mice by Immunization with Bacterial DNA (1989) (9)
Novel mechanism for estrogen receptor alpha modulation of murine lupus. (2019) (8)
Impact of sphingosine kinase on inflammatory pathways in fibroblast-like synoviocytes. (2011) (7)
Up‐Regulated Interleukin‐10 Induced by E2F Transcription Factor 2–MicroRNA‐17‐5p Circuitry in Extrafollicular Effector B Cells Contributes to Autoantibody Production in Systemic Lupus Erythematosus (2021) (6)
Complement Pathway Factor B Mice Genetically Deficient in the Alternative lpr Modulation of Renal Disease in MRL/ (1999) (6)
A Distinct Plasma Microbiome But Not Gut Microbiome in Patients With Systemic Lupus Erythematosus Compared to Healthy Individuals (2022) (6)
An Analytic Approach Using Candidate Gene Selection and Logic Forest to Identify Gene by Environment Interactions (G × E) for Systemic Lupus Erythematosus in African Americans (2018) (6)
A polymorphism within interleukin-21 receptor (IL21R) confers risk for systemic lupus erythematosus and is associated with malar rash in lupus patients (49.17) (2009) (6)
Mesenchymal Stem Cells from Chronic Pancreatitis Patients Show Comparable Potency Compared to Cells from Healthy Donors (2019) (6)
Intestinal macrophages in mucosal immunity and their role in systemic lupus erythematosus disease (2018) (6)
Acute gouty arthritis and intravenous nitroglycerin. (1988) (6)
Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus (2020) (6)
Nitric Oxide Induces Apoptosis in Spleen Lymphocytes from MRL/lpr Mice (2004) (5)
Amelioration of renal disease in lupus mice genetically deficient in complement factor B (1998) (5)
Comment on “Reassessment of the Role of Mut S Homolog 5 in Ig Class Switch Recombination Shows Lack of Involvement in cis- and trans-Switching” (2009) (4)
Glomerular Binding Antibodies in Systemic Lupus Erythematosus (1999) (4)
Genetic Landscape of Gullah African Americans (2020) (4)
Safety and Efficacy of Mesenchymal Stromal Cells and Other Cellular Therapeutics in Rheumatic Diseases in 2022: A Review of What We Know So Far (2022) (4)
Modulation of renal disease in lupus mice deficient in complement component C3 (1998) (4)
Complement-Targeted Therapies in Lupus (2015) (4)
Staphylococcus aureus peptidoglycan (PGN) induces pathogenic autoantibody production via autoreactive B cell receptor clonal selection, implications in systemic lupus erythematosus. (2022) (4)
Effect of Sex on the Induction of Anti-DNA Antibodies in Normal Mice Immunized with Bacterial DNA (1993) (4)
Association of PPP2CA polymorphisms with SLE susceptibility in multiple ethnic groups (2011) (3)
New therapies and preventive strategies to treat and minimize damage in lupus (2005) (3)
Effectiveness of Sublingual Clonidine in Patients Unable to Take Oral Medication (1987) (3)
Selective Cyclooxygenase-2 Inhibitor Suppresses Renal Thromboxane Production but Not Proliferative Lesions in the MRL/lpr Murine Model of Lupus Nephritis (2011) (3)
Angiotensin-patients with systemic lupus erythematosus (2004) (3)
Safety, immunological effects and clinical response in a phase I trial of umbilical cord mesenchymal stromal cells in patients with treatment refractory SLE (2022) (3)
Complement factor C3 is not required for full expression of lupus nephritis in MRL/lpr mice (2000) (3)
Variants within MECP2 , a key transcriptional regulator, are associated with increased susceptibility to lupus and differential gene expression in lupus patients (2011) (3)
The Role of Reactive Nitrogen and Oxygen Intermediates in Systemic Lupus Erythematosus (2011) (3)
Pulmonary Hypertension in Systemic Lupus Erythematosus (2008) (3)
Pre-Clinical Autoimmunity in Lupus Relatives: Self-Reported Questionnaires and Immune Dysregulation Distinguish Relatives Who Develop Incomplete or Classified Lupus From Clinically Unaffected Relatives and Unaffected, Unrelated Individuals (2022) (2)
P-0082: Role of complement and the use of complement Inhibitors in the Acute DSS Model of IBD (2009) (1)
Treating Systemic Lupus Erythematosus (SLE): The Impact of Historical Environmental Context on Healthcare Perceptions and Decision-Making in Charleston, South Carolina (2020) (1)
Mice lpr MRL/Manifestations of Autoimmune Disease in Protects against Renal Disease and Other Low-Dose Targeted Complement Inhibition (2007) (1)
erythematosus : a pilot clinical study transplantation in refractory systemic lupus Allogenic mesenchymal stem cells (2010) (1)
Georgia Abortion Law and Our Commitment to Patients (2020) (1)
Comparison of mesenchymal stem cells from healthy donor and chronic pancreatitis patients (2018) (1)
COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman (2022) (1)
Formal neurocognitive function and anti-N-methyl-D-aspartate receptor antibodies in paediatric lupus (2021) (1)
Fibrosing diseases : Diabetic Stiff Hand Syndrome , Dupuytren ' s Contracture , Palmar and Plantar Fasciitis , Retroperitoneal Fibrosis , and Peyronie ' s Disease (2018) (1)
Reactive Nitrogen Intermediates in the Pathogenesis of Systemic Lupus Erythematosus (2016) (1)
Smoking and secondhand smoke among patients with systemic lupus erythematosus and controls: associations with disease and disease damage (2014) (1)
Impacts of Gut Microbiota on Gender Bias in Intestinal Pro-Inflammatory Immune Phenotype and Systemic Autoimmune Progression in Lupus-prone SNF1 mice (2019) (1)
Inhibition of tight junction protein ZO-1 expression by estrogen in human gut mucosa (2017) (1)
The limitation and racial difference of the plasma microbiome in SLE disease. (2019) (1)
Effect on B Cell Function by Mesenchymal Stem Cells of Different Derivation (2015) (1)
Childhood-onset Systemic Lupus Erythematosus Complicated by Posterior Reversible Encephalopathy Syndrome in The Context of Kidney Dialysis and Plasma Exchange in Pediatric Lupus (2016) (1)
Estrogen receptor alpha deficiency protects against development of cognitive impairment in murine lupus (2014) (1)
Mice lpr Renal Disease in MRL/ Prolongs Survival and Significantly Reduces Transcription Factor Fli-1 Markedly Decreased Expression of the Ets Family (2004) (1)
Agonists γ Proliferator Activation Receptor-and 2 Mice by Prostaglandin J lpr MRL / Inhibition of Mesangial Cell Nitric Oxide in (2000) (1)
Differential efficacy of human mesenchymal stem cells on disease in murine lupus based on source of origin. (P4162) (2013) (1)
Role of Nitric Oxide in Podocyte Physiology in Lupus Nephritis (2012) (1)
70 R848 (Resiquimod), a TLR 7/8 agonist, accelerates disease and causes a fatal myeloproliferative disorder in NZM 2410 lupus-prone mice (2019) (0)
Deep sequencing reveals a DAP1 regulatory haplotype that potentiates autoimmunity in systemic lupus erythematosus (2020) (0)
PSS61 - Nitric Oxide Modulation of Redox-Modulated Cytokines in Lupus Nephritis (2013) (0)
Direct correlation between plasma microbial translocation and autoantibodies in first-degree relatives of patients with systemic lupus erythematosus (2018) (0)
Inhibition Of The Complement Anaphylatoxin, C3a, Signaling Reduces Inflammation In A Murine Model Of Atopic Chronic Rhinosinusitis (2012) (0)
Mice by Suberoylanilide Hydroxamic Acid lpr Modulation of Renal Disease in MRL / Marks and (2004) (0)
SLE and other connective tissue diseases (animal models) (WS-017) Chairpersons: Takayuki Sumida, Sachiko Hirose (2010) (0)
902 Loss-of-function variants inSAT1cause X-linked Childhood-onset Systemic Lupus Erythematosus (2022) (0)
Soluble mediators and clinical features predict transition to systemic lupus erythematosus classification in previously unaffected relatives of SLE patients (HUM3P.243) (2015) (0)
Age-related Changes in B cells Impact Immune Responses to Pneumococcal Vaccination in Aging HIV+ Individuals (2017) (0)
1207 Update on Progress of the Mesenchymal Stromal Cell Trial in Refractory Lupus (2022) (0)
Effect of lipoteichoic acid on B cells in female C57BL/6 mice (89.25) (2010) (0)
Effect of Sex on the Induction of Anti-DNA Antibodies in Normal Mice Immunized with Bacterial DNA (1993) (0)
Formative research to promote lupus awareness and early screening at Historically Black College and University (HBCU) communities in South Carolina (2022) (0)
Mice lpr MRL / MpJ-Fas Antibody-Producing Cells in the Kidneys of Enrichment of Anti-Glomerular Antigen (2004) (0)
361 HLA DRB1 ALLELES IN AFRICAN-AMERICANS WITH EARLY RHEUMATOID ARTHRITIS: PRELIMINARY RESULTS FROM 207 SUBJECTS IN THE CLEAR STUDY (2005) (0)
Targeted inhibition of the alternative pathway ameliorates progression of renal disease in murine models of systemic lupus erythematosus (2010) (0)
Conditional knockout of oestrogen receptor alpha in CD11c+ cells impacts female survival and inflammatory cytokine profile in murine lupus (2022) (0)
Erratum: Genetic associations of LYN with systemic lupus erythematosus (Genes and Immunity (2009) 10 (397-403) DOI: 10.1038/gene.2009.19) (2010) (0)
The Role of Nitric Oxide in the Pathogenesis of Spontaneous Murine Autoimmune Disease: Increased Nitric Oxide Production and Nitric Oxide Synthase Expression in MRL-lpr/lpr Mice, and Reduction of Spontaneous Glomerulonephritis .and Arthritis by Orally Administered NG-Monomethyl-L-Arglnlne (1994) (0)
Erratum: Complement receptor 2 polymorphisms associated with systemic lupus erythematosus modulate alternative splicing (Genes and Immunity (2009) vol. 10 (457-469) 10.1038/gene.2009.27) (2009) (0)
Understanding how immune checkpoint modulators alter pre-existing rheumatologic disorders in cancer patients (2017) (0)
Exploring the transcriptional impact of ERα in the B cell response of systemic lupus erythematosus (2020) (0)
Loss-of-function variants in SAT1 cause X-linked childhood-onset systemic lupus erythematosus (2022) (0)
Involvement of estrogen receptor alpha on MCP1 production in C57BL/6 kidney mesangial cells (87.29) (2010) (0)
The Multidimensional Burden of Systemic Lupus Erythematosus: Mortality Risk and Quality of Life Measures Early in the Course of the Disease (2007) (0)
Reactive Intermediates, Inflammation and Epigenetics in Lupus (2009) (0)
Cigarette Smoke Exacerbates Inflammation Associated With Chronic Rhinosinusitis (2012) (0)
Expression of GM-CSF is regulated by transcription factor Fli-1 (2019) (0)
Expression of granulocyte-macrophage colony-stimulating factor is regulated by Fli-1 transcription factor, a potential drug target (2021) (0)
-Switching'' trans - and cis Recombination Shows Lack of Involvement in Mut S Homolog 5 in Ig Class Switch Comment on ''Reassessment of the Role of (2009) (0)
1401 A Genome Wide Association Scan of SLE genetic risk in a cohort of African-American persons (2022) (0)
Acute Renal Failure in Mice Complement Pathway Ameliorates Ischemic Lack of a Functional Alternative (2013) (0)
Progesterone decreases gut permeability through upregulating occludin expression in primary human gut tissues and Caco-2 cells (2019) (0)
245 MYELOPEROXIDASE GENE POLYMORPHISM IN SYSTEMIC LUPUS ERYTHEMATOSUS AND LUPUS NEPHRITIS. (2006) (0)
Model of Systemic Lupus Erythematosus Selection and Renal Disease in a Murine Role of MHC-Linked Genes in Autoantigen Gilkeson (2006) (0)
Eliminating Alternative Complement Pathway Signaling Reduces CNV in a Mouse Model of Wet AMD (2008) (0)
Selective disruption of ER[alpha] expression in dendritic cells of lupus prone mice results in female-specific reduced survival (2018) (0)
Podocytes: A Potential Source of Nitric Oxide Production in Murine Lupus Nephritis (2010) (0)
Title Gene expression profile reveals abnormalities of multiple signaling pathways in mesenchymal stem cell derived from patients with systemic lupus erythematosus (2014) (0)
OR.104. Association of Sjögren's Syndrome (SS) and Systemic Lupus Erythematosus (SLE) with BLK (2008) (0)
Peroxisome Proliferation-Activated Receptor (PPAR) (cid:1) Is Not Necessary for Synthetic PPAR (cid:1) Agonist Inhibition of Inducible Nitric-Oxide Synthase and Nitric Oxide (2004) (0)
191 THE RESPONSE OF MRL/LPR-INDUCIBLE NITRIC OXIDE SYNTHASE KNOCKOUT MICE TO INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITOR. (2007) (0)
Fli-1 inhibitors reduce the production of inflammatory cytokines in human renal glomerular endothelial cells and ameliorate lupus nephritis in NZB/W F1 mice (2020) (0)
Inhibition of factor B, the alternative komplemenpathway and related method (2005) (0)
Reply (2019) (0)
Dialogue: Vitamin D, statins and atherosclerotic progression in paediatric lupus (2015) (0)
Title Allogeneic mesenchymal stem cell transplantation in severe andrefractory systemic lupus erythematosus : 4 years of experience (2013) (0)
180 Examining the transcriptional impact of liganded estrogen receptor alpha in the inflammatory milieu of systemic lupus erythematosus (2019) (0)
Gender differences at baseline in autoantibody levels but no gender differences in vaccine-induced responses and no changes in autoantibody levels following influenza vaccine (HUM6P.246) (2015) (0)
Targeted inhibition of the alternative pathway by CR2-fH fusion protein ameliorates progression of renal disease in MRL/lpr mice (2008) (0)
Sa.9. Common Variants within MECP2 Confer Risk of Systemic Lupus Erythematosus (2008) (0)
Sa.54. Positional Identification of Integrin- αMβ2 (ITGAM) as a Susceptibility Gene for Systematic Lupus Erythematosus (SLE) (2008) (0)
Light-Damage as a Model to Study Complement-Mediated Photoreceptor Degeneration (2007) (0)
DIAGNOSIS OF SYSTEMIC LUPUS ERYTHEMATOSUS SLE is highly variable in its clinical presentation and affects individ- ual patients with an intensity that varies over time. Among organ (1997) (0)
Decreased inflammatory dendritic cells in lupus prone ERαKO mice correlate with increased survival (BA4P.214) (2014) (0)
Absence of sphingosine kinase 1 alters progression of TNF-alpha induced arthritis (99.25) (2009) (0)
Effects of expression Fli1 transcription factor on lupus disease development in NZM2410 mice (99.35) (2009) (0)
154 Impact of diagnosis age on quality of life among patients with systemic lupus erythematosus (2019) (0)
Chapter 26 – Nitric Oxide in Systemic Lupus Erythematosus (2007) (0)
Fli-1 transcription factor affects inflammatory cell infiltration in the lupus nephritis development by regulating expression of inflammatory chemokines (44.12) (2011) (0)
Low gene copy of complement C4 is a common genetic risk factor for human systemic lupus erythematosus in three different racial groups (2008) (0)
Symposium S5: The Role of Complement in the Brain: The Good and the Bad (2004) (0)
Nitric Oxide in Systemic Lupus Erythematosus (2007) (0)
Complement Anaphylatoxins, C3a And C5a, Enhance Pro-Inflammatory Cytokine Production During Cigarette Smoke Induced Inflammation (2012) (0)
Blood relatives with incomplete lupus are distinguished from unaffected relatives and relatives with classified disease by altered autoantibodies, soluble inflammatory and regulatory mediators, and clinical features (2016) (0)
C8orf13/BLK association with systemic lupus erythematosus across different ethnicities (136.28) (2009) (0)
Disease in MRL-lpr / Ipr Mice Lacking Nitr ic O x i d e Synthase Type 2 By (2003) (0)
358 DIFFERENTIAL GENE EXPRESSION IN B CELLS FROM GULLAH LUPUS PATIENTS AND CONTROLS. (2005) (0)
Gene Expression Profile Reveals Abnormalities of Multiple Signaling Pathways inMesenchymal Stem Cell Derived from Patients with Systemic Lupus Erythematosus (2012) (0)
Trichloroethylene induces cachexia and fatty infiltrate of liver in MRL-Ipr mice (1998) (0)
Stem Cells Based on Source of Origin Differential Efficacy of Human Mesenchymal (2014) (0)
Identifying novel mechanisms regulating the expression of the inflammatory chemokine IP-10 (2018) (0)
P148. Serum nitrate and nitrite levels are greater in systemic lupus erythematosus and lupus nephritis in association with disease activity (2006) (0)
Modulation of anti-DNA production and renal disease in preimmune NZB/W mice by bacterial DNA immunization (1995) (0)
Alternative complement pathway signalling in a mouse model of choroidal neovascularisation (2008) (0)
Vaccinations in patients with systemic lupus erythematosus—safe, but not always effective (2006) (0)
Safety, Immunologic Effects and Clinical Response in a Phase I Trial of Umbilical Cord Mesenchymal Stromal Cells in Patients with Treatment Refractory Systemic Lupus Erythematosus (2022) (0)
Title Allogenic Mesenchymal Stem Cell Transplantation AmelioratesNephritis in Lupus Mice Via Inhibition of B-Cell Activation (2013) (0)
Multifactorial Contributions of Complement Initiation Pathways to Mouse Laser-Induced Choroidal Neovascularization (2010) (0)
Distinct genome-wide DNA methylation and gene expression signatures in classical monocytes from African American patients with systemic sclerosis (2022) (0)
AI-30 Gender differences in plasma levels of ANA, ANTI-CD4, and ANTI-DSDNA antibodies in healthy donors pre and post flu vaccination (2016) (0)
II-01 An oestrogen receptor alpha functional mutant is protective in murine lupus (2016) (0)
362 EFFECT OF INDUCIBLE NITRIC OXIDE SYNTHASE INHIBITORS ON ISOPROSTANE PRODUCTION IN MURINE LUPUS NEPHRITIS (2005) (0)
A9.15 Higher disease damage among african americans with familial versus sporadic systemic lupus erythematosus (2014) (0)
Gene regulation by a pathogenic anti-DNA antibody in murine lupus mesangial cells (2004) (0)
Medical Management of Systemic Lupus Erythematosus (2005) (0)
S-090: Seafood Consumption and Levels of Persistent Organic Pollutants in the Sea Island Gullah Community (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gary Steven Gilkeson?

Gary Steven Gilkeson is affiliated with the following schools:

Gary Steven Gilkeson's Academic­Influence.com Rankings

Gary Steven Gilkeson's Degrees

Why Is Gary Steven Gilkeson Influential?

Gary Steven Gilkeson's Published Works

Published Works

What Schools Are Affiliated With Gary Steven Gilkeson?

Gary Steven Gilkeson's AcademicInfluence.com Rankings